Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph-Edwards

Showing results (11-20 of 167) with videos related to

Pageof 17
Sort By:
Drug Safety|March 23, 2012
Clinical diagnosis: a topic worth revisiting for pharmacovigilanceI Ralph Edwards
Drug Safety|July 15, 2011
Conflicts of interest in medicines safety and regulation: how much conflict and how much interest should we allow?I Ralph Edwards
Drug Safety|February 25, 2009
Risk management of medicines and compensation for harmI Ralph Edwards
Drug Safety|July 14, 2009
Outliers and patients with adverse drug reactionsI Ralph Edwards
The International Journal of Risk & Safety in Medicine|April 14, 2020
News ItemIvor Ralph Edwards
Drug Safety|November 10, 2012
Communicating the new pharmacovigilance landscapeI Ralph Edwards
Lancet (London, England)|July 28, 2004
Intuition, evidence, and safetyI Ralph Edwards
Drug Safety|April 25, 2009
The good old drugs!I Ralph Edwards
Lancet (London, England)|April 18, 2003
Withdrawing drugs: nefazodone, the start of the latest sagaI Ralph Edwards
The International Journal of Risk & Safety in Medicine|March 23, 2012
Considerations on causality in pharmacovigilanceI Ralph Edwards
Pageof 17

Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
Drug Safety|March 23, 2012
Clinical diagnosis: a topic worth revisiting for pharmacovigilanceI Ralph Edwards
Drug Safety|July 15, 2011
Conflicts of interest in medicines safety and regulation: how much conflict and how much interest should we allow?I Ralph Edwards
Drug Safety|February 25, 2009
Risk management of medicines and compensation for harmI Ralph Edwards
Drug Safety|July 14, 2009
Outliers and patients with adverse drug reactionsI Ralph Edwards
The International Journal of Risk & Safety in Medicine|April 14, 2020
News ItemIvor Ralph Edwards
Drug Safety|November 10, 2012
Communicating the new pharmacovigilance landscapeI Ralph Edwards
Lancet (London, England)|July 28, 2004
Intuition, evidence, and safetyI Ralph Edwards
Drug Safety|April 25, 2009
The good old drugs!I Ralph Edwards
Lancet (London, England)|April 18, 2003
Withdrawing drugs: nefazodone, the start of the latest sagaI Ralph Edwards
The International Journal of Risk & Safety in Medicine|March 23, 2012
Considerations on causality in pharmacovigilanceI Ralph Edwards
Pageof 17